TRANXENE Safety Questions, TRANXENE Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides unique information about TRANXENE. Our extensive database of TRANXENE adverse events and TRANXENE warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Ask Our Health Experts about TRANXENE
TRANXENE Safety Reports
Total TRANXENE reports: 12.TRANXENE FDA safety alerts: No.
Reported hospitalizations: 7.
Take TRANXENE Side Effects Survey or Share Your TRANXENE Story. Read More Here.
Health Professional from UNITED STATES reported TRANXENE problem on Feb 15, 2007. Female patient, 36 years of age, was treated with TRANXENE. After drug was administered, patient experienced the following problems/side effects: suicide attempt. TRANXENE dosage: unknown. During the same period patient was treated with LUNESTA, MOTRIN. Patient recovered.
TRANXENE problem was reported by a Consumer or non-health professional from on Apr 23, 2007. Male patient, weighting 6.39 lb, was treated with TRANXENE. After drug was administered, patient experienced the following problems/side effects: anomaly of external ear congenital, dysmorphism, oesophageal atresia. TRANXENE dosage: unknown. During the same period patient was treated with CHLORPROMAZINE, RISPERIDONE, TROPATEPINE, BUPRENORPHINE. Patient recovered.
Consumer or non-health professional from UNITED STATES reported TRANXENE problem on Apr 14, 2007. Female patient, 80 years of age, was diagnosed with anxiety and was treated with TRANXENE. After drug was administered, patient experienced the following problems/side effects: asthenia, dermatitis allergic, disorientation, dyssomnia, headache, hypersensitivity, nausea, presyncope, rash. TRANXENE dosage: 3.75 MG; QD; PO. During the same period patient was treated with LEXAPRO, PAXIL. Patient was hospitalized. Patient recovered.
TRANXENE problem was reported by a Health Professional from FRANCE on June 26, 2006. Male patient, 35 years of age, was diagnosed with epilepsy, depression, mental disorder and was treated with TRANXENE. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, depression, mental disorder, pancreatitis. TRANXENE dosage: unknown. During the same period patient was treated with DEPAKENE, METRONIDAZOLE, ROXITHROMYCIN, HEPARIN, SERTRALINE, OLANZAPINE, BACLOFEN, POTASSIUM CHLORIDE. Patient was hospitalized. Patient recovered.
Health Professional from FRANCE reported TRANXENE problem on Aug 01, 2006. Male patient, 35 years of age, was diagnosed with epilepsy, febrile infection, depression, abnormal behaviour, mental disorder and was treated with TRANXENE. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, depression, febrile infection, femur fracture, hyperhidrosis, hypotension, mental disorder, pancreatic necrosis, pancreatitis acute. TRANXENE dosage: unknown. During the same period patient was treated with DEPAKENE, METRONIDAZOLE, ROXITHROMYCIN, HEPARIN, SERTRALINE, OLANZAPINE, BACLOFEN. Patient was hospitalized. Patient recovered.
TRANXENE problem was reported by a Consumer or non-health professional from FRANCE on Aug 17, 2006. Female patient, 55 years of age, was treated with TRANXENE. After drug was administered, patient experienced the following problems/side effects: ecchymosis, thrombocytopenia. TRANXENE dosage: 50 MG; QD; PO. During the same period patient was treated with VENLAFAXINE, CYAMEMAZINE, DEPAKOTE, HEPARIN. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from FRANCE reported TRANXENE problem on Aug 16, 2006. Male patient, 54 years of age, was diagnosed with abnormal behaviour and was treated with TRANXENE. After drug was administered, patient experienced the following problems/side effects: acute respiratory distress syndrome, depressed level of consciousness, hypotension. TRANXENE dosage: unknown. During the same period patient was treated with DEPAKOTE, TIAPRIDE, ASPIRIN, NULYTELY, PRAVASTATIN, VALPROMIDE. Patient was hospitalized. Patient recovered.
TRANXENE problem was reported by a Health Professional from UNITED STATES on Sept 25, 2006. Female patient was treated with TRANXENE. After drug was administered, patient experienced the following problems/side effects: coma, suicide attempt. TRANXENE dosage: unknown. During the same period patient was treated with ESCITALOPRAM OXALATE, ALIMEMAZINE TARTRATE. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from FRANCE reported TRANXENE problem on Sept 26, 2006. Male patient was diagnosed with epinephrine increased and was treated with TRANXENE. After drug was administered, patient experienced the following problems/side effects: condition aggravated, mania, paraesthesia, sleep disorder, suicidal ideation. TRANXENE dosage: unknown. During the same period patient was treated with KERLONE. Patient recovered.
TRANXENE problem was reported by a Physician from UNITED STATES on Oct 19, 2006. Female patient was diagnosed with epilepsy and was treated with TRANXENE. After drug was administered, patient experienced the following problems/side effects: anorexia, anxiety, insomnia, pruritus. TRANXENE dosage: 3.75 MG 2 TABS BID PO. Patient recovered.
Health Professional from FRANCE reported TRANXENE problem on Oct 11, 2006. Female patient, 28 years of age, was treated with TRANXENE. After drug was administered, patient experienced the following problems/side effects: abdominal pain, hepatic necrosis. TRANXENE dosage: unknown. During the same period patient was treated with ZOLPIDEM TARTRATE, GESTODENE AND ETHINYL ESTRADIOL, LORAZEPAM, DEROXAT. Patient was hospitalized. Patient recovered.
TRANXENE problem was reported by a Consumer or non-health professional from FRANCE on Nov 13, 2006. Female patient was diagnosed with epilepsy and was treated with TRANXENE. After drug was administered, patient experienced the following problems/side effects: caesarean section, oligohydramnios, threatened labour, uterine cervix dilation procedure. TRANXENE dosage: unknown. During the same period patient was treated with SUBUTEX, CORTICOSTEROIDS, TEGRETOL. Patient recovered.